Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oric Pharmaceuticals Inc.

10.23
-0.2600-2.48%
Post-market: 10.230.00000.00%19:49 EDT
Volume:794.31K
Turnover:8.32M
Market Cap:871.78M
PE:-5.44
High:10.87
Open:10.32
Low:10.20
Close:10.49
Loading ...
Mar 23, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 22, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Nov 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 19, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Major Issues Report

8-K - Current report
May 20, 2020

Major Issues Report

8-K - Current report